Skip to content

Evaluation of gastroesophageal reflux disease

Evaluation of gastroesophageal reflux disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082990
Enrollment
Unknown
Registered
2024-04-12
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroesophageal reflux disease

Interventions

Gastroesophageal Reflux Group:No

Sponsors

Central Hospital of Zibo
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patient with gastroscopically confirmed reflux esophagitis

Exclusion criteria

Exclusion criteria: Patients with severe organic diseases, those who could not cooperate with the survey, those with mental illness, and others whom the investigator considered unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Gastroesophageal Reflux Symptom Scale;Basic Information;PSSS Scale;Beck Scale;GAD-7;

Secondary

MeasureTime frame
Symptom Inventory Scale;MDIScale;PHQ-9;

Countries

China

Contacts

Public ContactGaozhong li

Central Hospital of Zibo

ligaozhong05@163.com+86 186 7818 6361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026